Tang Capital Management LLC Molecular Partners Ag Transaction History

Tang Capital Management LLC

  • $1.17 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$3.32 - $11.01 $323,700 - $1.07 Million
-97,500 Reduced 97.5%
2,500 $18,000
Q4 2023

Feb 14, 2024
BUY
$3.53 - $4.62 $212,671 - $278,341
60,247 Added 151.55%
100,000 $418,000
Q2 2023

Aug 14, 2023
BUY
$5.81 - $6.93 $8,715 - $10,395
1,500 Added 3.92%
39,753 $247,000
Q1 2023

May 15, 2023
BUY
$5.8 - $7.32 $94,267 - $118,971
16,253 Added 73.88%
38,253 $231,000
Q4 2022

Feb 14, 2023
BUY
$6.03 - $7.08 $132,660 - $155,760
22,000 New
22,000 $144,000

Others Institutions Holding MOLN

# of Institutions
6
Shares Held
849K
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $181M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email